The current valuation score of Centessa Pharmaceuticals PLC is 6.80, ranking 295 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is -22.55, which is -94.19% below the recent high of -1.31 and -21.17% above the recent low of -27.32.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.